Ropes & Gray represented Xeris Biopharma Holdings on the deal. Xeris Biopharma Holdings announced a platform research evaluation, collaboration and option agreement with Regeneron Pharmaceuticals, Inc....
You must be a Standard 1 Year member to access this content.
Paul Weiss advised EQT Infrastructure VI fund, and Ropes & Gray advised Harvest Partners and Lazer Logistics. EQT announced that the EQT Infrastructure VI fund (EQT Value-Add...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Parthenon Investors VII on the deal. Parthenon Investors VII (“Parthenon Fund VII”), affiliate of Parthenon Capital, announced the closing of its first and...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised New Mountain Capital and its portfolio company The Emmes Company on the deal. Emmes, a global, full-service Clinical Research Organization (CRO) dedicated...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Bain Capital on the deal. Bain Capital announced the closing of Bain Capital Tech Opportunities Fund II, L.P. The fund closed with $2.4...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented FB Debt Financing Guarantor, LLC and certain of its subsidiaries on the deal. FB Debt Financing Guarantor, LLC and certain of its...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Bain Capital Ventures on the deal. Bain Capital Ventures announced the closing of Bain Capital Ventures Co-Investment Fund IV. The fund closed with...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Bain Capital Ventures on the deal. Bain Capital Ventures announced the closing of Bain Capital Venture Fund 2022. The fund closed with $1.4...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Lyric Capital Group on the deal. Lyric Capital Group announced the closing of its second music royalty fund, Lyric Capital Royalty Fund II....
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented ImmunoGen, Inc. on the deal. ImmunoGen, Inc., a leader in the field of antibody-drug conjugates, announced a global, multi-target license and option agreement...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Amarin Corporation plc on the deal. Pharmaceutical company Amarin Corporation plc announced an agreement with CSL Seqirus for an exclusive license and distribution...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Silver Lake on the deal. Silver Lake and its portfolio company Weld North Education announced the add-on acquisition of Winsor Learning, a producer...
You must be a Standard 1 Year member to access this content.
